Literature DB >> 29392534

Overexpression of WNK1 in POMC-expressing neurons reduces weigh gain via WNK4-mediated degradation of Kir6.2.

Woo Young Chung1, Jung Woo Han1, Woon Heo1, Min Goo Lee1, Joo Young Kim2.   

Abstract

"With no lysine" (WNK) kinases have been shown to regulate various ion transporters in various tissues, but studies on the function of WNK kinases in the brain have been limited. In this study, we discovered that WNK1 and WNK4 in POMC-expressing neuronal cells in WNK1 overexpressed transgenic mice (WNK1 TG) decrease appetite via degradation of Kir6.2. Weight gain after 20 weeks of age was delayed in WNK1 TG mice as a result of reduced food intake. Expression of WNK1 and proopiomelanocortin (POMC) was higher in POMC-expressing neurons in the hypothalamus of WNK1 TG mice than in WT mice. Immunostaining of serial sections of the hypothalamus revealed that POMC-expressing neurons were smaller in WNK1 TG mice than in WT mice. In addition, expression of Kir6.2 was significantly reduced in WNK1 TG mice. Overexpression and knockdown of WNK4 demonstrated that WNK4 regulates protein expression of Kir6.2 via protein-protein interaction. Accordingly, reduced age-dependent weight gain of WNK1 TG mice seems to be related with the decreased Kir6.2 expression via WNK1- and WNK4-regulated protein stability of Kir6.2.

Entities:  

Keywords:  Appetite; Kir6.2; POMC-expressing neuron; Protein degradation; Transgenic mice; WNK1; WNK4

Mesh:

Substances:

Year:  2018        PMID: 29392534     DOI: 10.1007/s11010-018-3301-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.

Authors:  B Xu; J M English; J L Wilsbacher; S Stippec; E J Goldsmith; M H Cobb
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

2.  ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis.

Authors:  T Miki; B Liss; K Minami; T Shiuchi; A Saraya; Y Kashima; M Horiuchi; F Ashcroft; Y Minokoshi; J Roeper; S Seino
Journal:  Nat Neurosci       Date:  2001-05       Impact factor: 24.884

3.  Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculature.

Authors:  Hyun Woo Park; Joo Young Kim; Soo-Kyoung Choi; Young-Ho Lee; Weizhong Zeng; Kyung Hwan Kim; Shmuel Muallem; Min Goo Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

4.  Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule.

Authors:  Maria D Lalioti; Junhui Zhang; Heather M Volkman; Kristopher T Kahle; Kristin E Hoffmann; Hakan R Toka; Carol Nelson-Williams; David H Ellison; Richard Flavell; Carmen J Booth; Yin Lu; David S Geller; Richard P Lifton
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

Review 5.  Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases.

Authors:  Juliette Hadchouel; David H Ellison; Gerardo Gamba
Journal:  Annu Rev Physiol       Date:  2016       Impact factor: 19.318

6.  Rapamycin ameliorates age-dependent obesity associated with increased mTOR signaling in hypothalamic POMC neurons.

Authors:  Shi-Bing Yang; An-Chi Tien; Gayatri Boddupalli; Allison W Xu; Yuh Nung Jan; Lily Yeh Jan
Journal:  Neuron       Date:  2012-08-09       Impact factor: 17.173

7.  Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.

Authors:  Akihito Ohta; Tatemitsu Rai; Naofumi Yui; Motoko Chiga; Sung-Sen Yang; Shih-Hua Lin; Eisei Sohara; Sei Sasaki; Shinichi Uchida
Journal:  Hum Mol Genet       Date:  2009-07-24       Impact factor: 6.150

8.  Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II.

Authors:  Masoud Shekarabi; Nathalie Girard; Jean-Baptiste Rivière; Patrick Dion; Martin Houle; André Toulouse; Ronald G Lafrenière; Freya Vercauteren; Pascale Hince; Janet Laganiere; Daniel Rochefort; Laurence Faivre; Mark Samuels; Guy A Rouleau
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

9.  Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.

Authors:  Guojin Wu; Ji-Bin Peng
Journal:  FEBS Lett       Date:  2013-05-09       Impact factor: 4.124

10.  Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.

Authors:  Koichiro Susa; Eisei Sohara; Tatemitsu Rai; Moko Zeniya; Yutaro Mori; Takayasu Mori; Motoko Chiga; Naohiro Nomura; Hidenori Nishida; Daiei Takahashi; Kiyoshi Isobe; Yuichi Inoue; Kenta Takeishi; Naoki Takeda; Sei Sasaki; Shinichi Uchida
Journal:  Hum Mol Genet       Date:  2014-05-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.